BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 34230155)

  • 1. Proton Beam Therapy for Local Recurrence of Rectal Cancer.
    Hiroshima Y; Ishikawa H; Murakami M; Nakamura M; Shimizu S; Enomoto T; Oda T; Mizumoto M; Nakai K; Okumura T; Sakurai H
    Anticancer Res; 2021 Jul; 41(7):3589-3595. PubMed ID: 34230155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton beam reirradiation for locally recurrent rectal cancer patients with prior pelvic irradiation.
    Takagawa Y; Suzuki M; Seto I; Azami Y; Machida M; Takayama K; Sulaiman NS; Nakasato T; Kikuchi Y; Murakami M; Honda M; Teranishi Y; Kono K
    J Radiat Res; 2024 May; 65(3):379-386. PubMed ID: 38604182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ablative dose proton beam therapy for stage I and recurrent non-small cell lung carcinomas : Ablative dose PBT for NSCLC.
    Lee SU; Moon SH; Cho KH; Pyo HR; Kim JY; Kim DY; Kim TH; Suh YG; Kim YJ
    Strahlenther Onkol; 2016 Sep; 192(9):649-57. PubMed ID: 27282279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton beam therapy in rectal cancer: A systematic review and meta-analysis.
    Fok M; Toh S; Easow J; Fowler H; Clifford R; Parsons J; Vimalachandran D
    Surg Oncol; 2021 Sep; 38():101638. PubMed ID: 34340196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy and dosimetry analysis of CT-guided
    Wang L; Wang H; Jiang Y; Ji Z; Guo F; Jiang P; Li X; Chen Y; Sun H; Fan J; Li W; Li X; Wang J
    Radiat Oncol; 2020 Jul; 15(1):179. PubMed ID: 32711542
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Standard fractionation external beam radiotherapy with and without intraoperative radiotherapy for locally recurrent rectal cancer: the role of local therapy in patients with a high competing risk of death from distant disease.
    Kishan AU; Voog JC; Wiseman J; Cook RR; Ancukiewicz M; Lee P; Ryan DP; Clark JW; Berger DL; Cusack JC; Wo JY; Hong TS
    Br J Radiol; 2017 Aug; 90(1076):20170134. PubMed ID: 28613934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Proton beam therapy reirradiation for breast cancer: Multi-institutional prospective PCG registry analysis.
    Thorpe CS; Niska JR; Girardo ME; Kosiorek HE; McGee LA; Hartsell WF; Larson GL; Tsai HK; Rossi CJ; Rosen LR; Vargas CE
    Breast J; 2019 Nov; 25(6):1160-1170. PubMed ID: 31338974
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of locally recurrent rectal carcinoma--results and prognostic factors.
    Wong CS; Cummings BJ; Brierley JD; Catton CN; McLean M; Catton P; Hao Y
    Int J Radiat Oncol Biol Phys; 1998 Jan; 40(2):427-35. PubMed ID: 9457832
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcome in patients with resectable locally recurrent rectal cancer after total mesorectal excision with and without previous neoadjuvant radiotherapy for the primary rectal tumor.
    Alberda WJ; Verhoef C; Nuyttens JJ; Rothbarth J; van Meerten E; de Wilt JH; Burger JW
    Ann Surg Oncol; 2014 Feb; 21(2):520-6. PubMed ID: 24121879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proton Beam Therapy for Histologically or Clinically Diagnosed Stage I Non-Small Cell Lung Cancer (NSCLC): The First Nationwide Retrospective Study in Japan.
    Ohnishi K; Nakamura N; Harada H; Tokumaru S; Wada H; Arimura T; Iwata H; Sato Y; Sekino Y; Tamamura H; Mizoe JE; Ogino T; Ishikawa H; Kikuchi Y; Okimoto T; Murayama S; Akimoto T; Sakurai H
    Int J Radiat Oncol Biol Phys; 2020 Jan; 106(1):82-89. PubMed ID: 31580927
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment results of alternating chemoradiotherapy followed by proton beam therapy boost combined with intra-arterial infusion chemotherapy for stage III-IVB tongue cancer.
    Takayama K; Nakamura T; Takada A; Makita C; Suzuki M; Azami Y; Kato T; Hayashi Y; Ono T; Toyomasu Y; Hareyama M; Kikuchi Y; Daimon T; Mitsudo K; Tohnai I; Fuwa N
    J Cancer Res Clin Oncol; 2016 Mar; 142(3):659-67. PubMed ID: 26521257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and feasibility of proton beam radiotherapy using the simultaneous integrated boost technique for locally advanced pancreatic cancer.
    Kim TH; Lee WJ; Woo SM; Oh ES; Youn SH; Jang HY; Han SS; Park SJ; Suh YG; Moon SH; Kim SS; Kim DY
    Sci Rep; 2020 Dec; 10(1):21712. PubMed ID: 33303947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment and survival of locally recurrent rectal cancer: A cross-sectional population study 15 years after the Dutch TME trial.
    Detering R; Karthaus EG; Borstlap WAA; Marijnen CAM; van de Velde CJH; Bemelman WA; Beets GL; Tanis PJ; Aalbers AGJ;
    Eur J Surg Oncol; 2019 Nov; 45(11):2059-2069. PubMed ID: 31230980
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose proton beam therapy for sinonasal mucosal malignant melanoma.
    Fuji H; Yoshikawa S; Kasami M; Murayama S; Onitsuka T; Kashiwagi H; Kiyohara Y
    Radiat Oncol; 2014 Jul; 9():162. PubMed ID: 25056641
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical Outcomes and Prognostic Factors of High-Dose Proton Beam Therapy for Peripheral Stage I Non-Small-Cell Lung Cancer.
    Hatayama Y; Nakamura T; Suzuki M; Azami Y; Ono T; Yabuuchi T; Hayashi Y; Kimura K; Hirose K; Wada H; Hareyama M; Kikuchi Y; Takai Y
    Clin Lung Cancer; 2016 Sep; 17(5):427-432. PubMed ID: 26725851
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative toxicity outcomes of proton-beam therapy versus intensity-modulated radiotherapy for prostate cancer in the postoperative setting.
    Santos PMG; Barsky AR; Hwang WT; Deville C; Wang X; Both S; Bekelman JE; Christodouleas JP; Vapiwala N
    Cancer; 2019 Dec; 125(23):4278-4293. PubMed ID: 31503338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radicality of resection and survival after multimodality treatment is influenced by subsite of locally recurrent rectal cancer.
    Kusters M; Dresen RC; Martijn H; Nieuwenhuijzen GA; van de Velde CJ; van den Berg HA; Beets-Tan RG; Rutten HJ
    Int J Radiat Oncol Biol Phys; 2009 Dec; 75(5):1444-9. PubMed ID: 19395199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systematic assessment of clinical outcomes and toxicities of proton radiotherapy for reirradiation.
    Verma V; Rwigema JM; Malyapa RS; Regine WF; Simone CB
    Radiother Oncol; 2017 Oct; 125(1):21-30. PubMed ID: 28941560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcomes of Patients With Primary Sacral Chordoma Treated With Definitive Proton Beam Therapy.
    Aibe N; Demizu Y; Sulaiman NS; Matsuo Y; Mima M; Nagano F; Terashima K; Tokumaru S; Hayakawa T; Suga M; Daimon T; Suzuki G; Hideya Y; Yamada K; Sasaki R; Fuwa N; Okimoto T
    Int J Radiat Oncol Biol Phys; 2018 Mar; 100(4):972-979. PubMed ID: 29485077
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate dose intraoperative and external beam radiotherapy for locally recurrent rectal carcinoma.
    Eble MJ; Lehnert T; Treiber M; Latz D; Herfarth C; Wannenmacher M
    Radiother Oncol; 1998 Nov; 49(2):169-74. PubMed ID: 10052883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.